WASHINGTON — Flagship Pioneering, the venture capital firm behind Moderna, is getting into the Washington lobbying game.
The firm has hired one of biopharma’s favorite lobbying shops to advocate on their behalf with Congress and the Biden administration, according to a new federal disclosure.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
